Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Alibaba Health Information Technology ( (HK:0241) ) has issued an announcement.
Alibaba Health Information Technology Limited has announced the grant of 1,701,000 share options to a connected grantee and 44,682,300 restricted share units to 594 grantees under its 2024 Share Award Scheme. This strategic move aims to incentivize and retain key personnel, potentially enhancing the company’s operational efficiency and market competitiveness.
The most recent analyst rating on (HK:0241) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on Alibaba Health Information Technology stock, see the HK:0241 Stock Forecast page.
More about Alibaba Health Information Technology
Alibaba Health Information Technology Limited operates in the healthcare technology industry, focusing on providing digital healthcare services and solutions. It is a subsidiary of Alibaba Group and is listed on the Hong Kong Stock Exchange.
Average Trading Volume: 102,818,384
Technical Sentiment Signal: Hold
Current Market Cap: HK$74.14B
See more insights into 0241 stock on TipRanks’ Stock Analysis page.